ZYME vs ZTS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

ZYME

45.1
AI Score
VS
ZTS Wins

ZTS

49.7
AI Score

Investment Advisor Scores

ZYME

45score
Recommendation
HOLD

ZTS

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ZYME ZTS Winner
Forward P/E 21.9298 11.2994 ZTS
PEG Ratio 0 1.8524 Tie
Revenue Growth -91.1% 2.9% ZTS
Earnings Growth 0.0% 6.0% ZTS
Tradestie Score 45.1/100 49.7/100 ZTS
Profit Margin -126.3% 28.0% ZTS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ZYME 1M: -10.0% · 3M: -14.9% ZTS 1M: +0.8% · 3M: -32.5%

Current Technical Phase

ZYME

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.3%), weak momentum, RSI 44

RSI (14): 43.6 · Price: $22.79

ZTS

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -8.9%) with fading momentum, RSI 46

RSI (14): 46.4 · Price: $76.04

Fundamentals Snapshot

Metric ZYME ZTS
Market Cap
Forward P/E 27.5 10.3
Trailing P/E 12.6
Revenue (TTM)
Revenue Growth -0.9% 0.0%
Gross Margin -0.7% 0.7%
Operating Margin -19.6% 0.4%
EPS -1.37 6.10
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, ZTS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.